
Sign up to save your podcasts
Or


CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP
By American College of Chest Physicians4.2
6262 ratings
CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP

1,876 Listeners

319 Listeners

502 Listeners

38 Listeners

6 Listeners

37 Listeners

3,387 Listeners

1,141 Listeners

521 Listeners

367 Listeners

258 Listeners

440 Listeners

376 Listeners

57 Listeners

272 Listeners